Adenovirus vector-mediated perforin expression driven by a glucocorticoid-inducible promoter inhibits tumor growth in vivo

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 6, 1998, Pages 936-941

  Ko, Narumi ^a   Kojima, Akira ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN;

ADENOVIRUS; ANIMAL; ARTICLE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CELL DEATH; CELL DIVISION; CYTOTOXIC T LYMPHOCYTE; GENE VECTOR; GENETICS; LUNG TUMOR; MOUSE; NUDE MOUSE; PATHOLOGY; PROMOTER REGION;

ADENOVIRIDAE; ANIMALS; CELL DEATH; CELL DIVISION; DEXAMETHASONE; GENETIC VECTORS; GLUCOCORTICOIDS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; PORE FORMING CYTOTOXIC PROTEINS; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032246699     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.6.3289     Document Type: Article

References (55)

1. Berke, G. 1995. The CTL's kiss of death. Cell 81:9-12.
2. Liu, C. C., C. M. Walsh, and J. D. Young. 1995. Perforin: structure and function. Immunol. Today 16:194-201.
3. Smyth, M. J. 1995. Dual mechanisms of lymphocyte-mediated cytotoxicity serve to control and deliver the immune response. Bioessays 17:891-898.
4. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207-232.
5. Podack, E. R., and G. Dennert. 1983. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 302:442-445.
6. Young, J. D., H. Hengartner, E. R. Podack, and Z. A. Cohn. 1986. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 44:849-859.
7. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343-346.
8. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37.
9. van den Broek, M. E., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W. K. Lutz, C. J. Melief, R. M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781-1790.
10. Mader, S., and J. H. White. 1993. A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells. Proc. Natl. Acad. Sci. USA 90:5603-5607.
11. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. B. Guggino, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
12. Rosenfeld, M. A., W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L. E. Stier, P. K. Paakko, P. Gilardi, L. D. Stratford-Perricaudet, M. Perricaudet, S. Jallat, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1991. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431-434.
13. Jantzen, H. M., U. Strahle, B. Gloss, F. Stewart, W. Schmid, M. Boshart, R. Miksicek, and G. Schutz. 1987. Cooperativety of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49:29-38.
14. Shinkai, Y., M. C. Yoshida, K. Maeda, T. Kobata, K. Maruyama, J. Yodoi, H. Yagita, and K. Okumura. 1989. Molecular cloning and chromosomal assignment of a human perforin (PFP) gene. Immunogenetics 30:452-457.
15. Korst, R. J., B. Bewig, and R. G. Crystal. 1995. In vitro and in vivo transfer and expression of human surfactant Sp-A- and Sp-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors. Hum. Gene Ther. 6:277-287.
16. McGrory, W. J., D. S. Bautista, and F. L. Graham. 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163:614-617.
17. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell Biol. 2:1044-1051.
18. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
19. Hersh, J., R. G. Crystal, and B. Bewig. 1995. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2:124-131.
20. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
21. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
22. Tso, J. Y., X. H. Sun, T. H. Kao, K. S. Recce, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
23. Neumann, J. R., C. A. Morency, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5:444-447.
24. Hirschowitz, E. A., A. Ohwada, W. R. Pascal, T. J. Russi, and R. G. Crystal. 1995. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6:1055-1063.
25. Young, J. D., Z. A. Cohn, and E. R. Podack. 1986. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. Science 233:184-190.
26. Shinkai, Y., K. Takio, and K. Okumura. 1988. Homology of perforin to the ninth component of complement (C9). Nature 334:525-527.
27. Shi, L., C. M. Kam, J. C. Powers, R. Aebersold, and A. H. Greenberg. 1992. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med. 176:1521-1529.
28. Shiver, J. W., L. Su, and P. A. Henkart. 1992. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 71:315-322.
29. Nakajima, H., H. L. Park, and P. A. Henkart. 1995. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J. Exp. Med. 181: 1037-1046.
30. Podack, E. R., J. D. Young, and Z. A. Cohn. 1985. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc. Natl. Acad. Sci. USA 82:8629-8633.
31. Tschopp, J., D. Masson, and K. K. Stanley. 1986. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Nature 322:831-834.
32. Apasov, S., F. Redegeld, and M. Sitkovsky. 1993, Cell-mediated cytotoxicity: contact and secreted factors. Curr. Opin. Immunol. 5:404-410.
33. Atkinson, E. A., and R. C. Bleackley. 1995. Mechanisms of lysis by cytotoxic T cells. Crit. Rev. Immunol. 15:359-384.
34. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
35. Smyth, M. J., and J. A. Trapani. 1995. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today 16:202-206.
36. Fauci, A. S., and D. C. Dale. 1975. The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood 46:235-243.
37. Haynes, B. F., and A. S. Fauci. 1978. The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J. Clin. Invest. 61:703-707.
38. Sebaldt, R. J., J. R. Sheller, J. A. Oates, L. J. Roberts II, and G. A. FitzGerald. 1990. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc. Natl. Acad. Sci. USA 87:6974-6978.
39. Klebl, F. H., G. Weber, J. R. Kalden, and H. G. Nusslein. 1994. In vitro and in vivo effect of glucocorticoids on IgE and IgG subclass secretion. Clin. Exp. Allergy 24:1022-1029.
40. Sackstein, R., and M. Borenstein. 1995. The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration. J. Invest. Med. 43:68-77.
41. Brigham, K. L., B. Meyrick, B. Christman, J. T. Conary, G. King, L. C. Berry, Jr., and M. A. Magnuson. 1993. Expression of human growth hormone fusion genes in cultured lung endothelial cells and in the lungs of mice. Am. J. Respir. Cell Mol. Biol. 8:209-213.
42. Fishman, G. I., M. L. Kaplan, and P. M. Buttrick. 1994. Tetracycline-regulated cardiac gene expression in vivo. J. Clin. Invest. 93:1864-1868.
43. Hayashi, Y., A. M. De Paoli, C. F. Burant, and S. Refetoff. 1994. Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J. Biol. Chem. 269:23872-23875.
44. Hallahan, D. E., H. J. Mauceri, L. P. Seung, E. J. Dunphy, J. D. Wayne, N. N. Hanna, A. Toledano, S. Hellman, D. W. Kufe, and R. R. Weichselbaum. 1995. Spatial and temporal control of gene therapy using ionizing radiation. Nature Med. 1:786-791.
45. Varley, A. W., M. G. Coulthard, R. S. Meidell, R. D. Gerard, and R. S. Munford. 1995. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc. Natl. Acad. Sci. USA 92: 5346-5350.
46. Wang, C., L. Chao, and J. Chao. 1995. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 95:1710-1716.
47. Ho, D. Y., J. R. McLaughlin, and R. M. Sapolsky. 1996. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Brain Res. Mol. Brain Res. 41:200-209.
48. Liang, X., J. Hartikka, L. Sukhu, M. Manthorpe, and P. Hobart. 1996. Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Ther. 3:350-356.
49. Suzuki, M., R. N. Singh, and R. G. Crystal. 1996. Regulatable promoters for use in gene therapy applications: modification of the 5′-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP. Hum. Gene Ther. 7:1883-1893.
50. Suzuki, M., R. N. Singh, and R. G. Crystal. 1998. Pharmacologic induction of hepatic expression of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cAMP response elements. Hepatology 27:160-165.
51. Pai, L. H., and I. Pastan. 1997. Immunotoxin therapy. In Cancer: Principles and Practice of Oncology. V. T. J. DeVita, S. Hellman, and S. A. Rosenberg, editors. Lippincott-Raven, Philadelphia. 3045-3057.
52. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
53. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2:545-550.
54. Wilson, J. M. 1996. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334:1185-1187.
55. Magovern, C. J., C. A. Mack, J. Zhang, T. K. Rosengart, O. W. Isom, and R. G. Crystal. 1997. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum. Gene Ther. 8:215-227.